Dissociation between serotonin neurotoxicity and brain-derived neurotrophic factor induction following neonatal MDMA exposure in rats

Developmental Neuroscience

Volumn 31, Issue 1-2, 2009, Pages 90-94

  Piper, Brian J ^a   Farelli, Jeremiah D ^a   Meyer, Jerrold S ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

3,4 Methylenedioxymethamphetamine; Brain derived neurotrophic factor; Ecstasy; Rats; Serotonin transporter

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; BRAIN DERIVED NEUROTROPHIC FACTOR; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; HIPPOCAMPUS; MALE; NEUROTOXICITY; NONHUMAN; OCCIPITAL CORTEX; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

AGING; ANIMALS; ANIMALS, NEWBORN; BRAIN CHEMISTRY; BRAIN-DERIVED NEUROTROPHIC FACTOR; CEREBRAL CORTEX; HALLUCINOGENS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEOSTRIATUM; NERVE FIBERS; NEUROTOXICITY SYNDROMES; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; UP-REGULATION;

EID: 65349160991     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000207497     Document Type: Article

References (29)

1. Boot BP, McGregor IS, Hall W (2000): MDMA (ecstasy) neurotoxicity: assessing and communicating the risks. Lancet 355: 1818-1821.
2. Bregman BS, McAtee M, Dai HN, Kuhn PL (1997): Neurotrophic factors increase axonal growth after spinal cord injury and transplantation in the adult rat. Exp Neurol 148: 475-494.
3. Callahan BT, Cord BJ, Ricaurte GA (2001): Longterm impairment of anterograde axonal transport along fiber projections originating in the rostral raphe nuclei after treatment with fenfluramine or methylenedioxymethamphetamine. Synapse 40: 113-121.
4. Degenhardt L, Barker B, Topp L (2004): Patterns of ecstasy use in Australia: findings from a national household survey. Addiction 99: 187-195.
5. Dobbing J, Sands J (1979): Comparative aspects of the brain growth spurt. Early Hum Dev 3: 79-83.
6. Gibbs RB (1998): Levels of trkA and BDNF mRNA, but not NGF mRNA, fluctuate across the estrous cycle and increase in response to acute hormone replacement. Brain Res 787: 259-268.
7. Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI (2003): The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'). Pharmacol Rev 55: 463-508.
8. Grider MH, Mamounas LA, Le W, Shine HD (2005): In situ expression of brain-derived neurotrophic factor of neurotrophin-3 promotes sprouting of cortical serotonergic axons following a neurotoxic lesion. J Neurosci Res 84: 404-412.
9. Hatzidimitriou G, McCann UD, Ricaurte GA (1999): Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. J Neurosci 19: 5096-5107.
10. Ho EL, Karimi-Tabesh L, Koren G (2002): Characteristics of pregnant women who use ecstasy (3,4-methylenedioxymethamphetamine). Neurotoxicol Teratol 23: 561-567.
11. Jin Y, Tessler A, Fischer I, Houle JD (2000): Fibroblasts genetically modified to produce BDNF support regrowth of chronically injured serotonergic axons. Neurorehabil Neural Repair 14: 311-317.
12. Johnson LD, O'Malley PM, Bachman JG, Schulenberg JE (2007): Monitoring the future national survey results on drug use, 1975-2006. Volume I: secondary school students (NIH publication No. 07-6205). Bethesda, National Institute on Drug Abuse.
13. Kelly PA, Ritchie IM, Quate L, McBean DE, Olverman HJ (2002): Functional consequences of perinatal exposure to 3,4-methylenedioxymethamphetamine in rat brain. Brit J Pharmacol 137: 963-970.
14. Koprich JB, Campbell NG, Lipton JW (2003): Neonatal 3,4- methylenedioxymethamphetamine (ecstasy) alters dopamine and serotonin neurochemistry and increases brainderived neurotrophic factor in the forebrain and brainstem of the rat. Dev Brain Res 147: 177-182.
15. Luellen BA, Szapacs ME, Materese CK, Andrews AM (2006): The neurotoxin 2 -NH 2 -MPTP degenerates serotonin axons and evokes increases in hippocampal BDNF. Neuropharmacology 50: 297-308.
16. Madhav TR, Pei Q, Zetterström TS (2001): Serotonergic cells of the rat raphe nuclei express mRNA of tyrosine kinase B (trkB), the highaffinity receptor for brain derived neurotrophic factor (BDNF). Mol Brain Res 93: 56-63.
17. Mamounas LA, Altar CA, Blue ME, Kaplan DR, Tessarollo L, Lyons WE (2000): BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. J Neurosci 20: 771-782.
18. Martínez-Turrillas R, Moyano S, Del Río J, Frechilla D (2006): Differential effects of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on BDNF mRNA expression in rat frontal cortex and hippocampus. Neurosci Lett 402: 126-130.
19. Mattson MP, Maudsley S, Martin B (2004): BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci 27: 589-594.
20. Meyer JS, Grande M, Johnson K, Ali SF (2004): Neurotoxic effects of MDMA ('ecstasy') administration to neonatal rats. Int J Dev Neurosci 22: 261-271.
21. Piper BJ (2007): A developmental comparison of the neurobehavioral effects of ecstasy (MDMA). Neurotoxicol Teratol 29: 288-300.
22. Piper BJ, Meyer JS (2006): Increased responsiveness to MDMA in adult rats treated neonatally with MDMA. Neurotoxicol Teratol 28: 95-102.
23. Piper BJ, Fraiman JB, Meyer JS (2005): Repeated MDMA ('ecstasy') exposure in adolescent male rats alters temperature regulation, spontaneous motor activity, attention, and serotonin transporter levels. Dev Psychobiol 47: 145-157.
24. Ramer LM, McPhail LT, Borisoff JF, Soril LJJ, Kaan TKY, Lee JHT, Saunders JWT, Hwi LPR, Ramer MS (2007): Endogenous trkB ligands suppress functional mechanosensory plasticity in the deafferented spinal cord. J Neurosci 27: 5812-5822.
25. Ricaurte GA, McCann UD, Szabo Z, Scheffel U (2000): Toxicodynamics and long-term toxicity of the recreational drug, 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'). Toxicol Lett 112: 143-146.
26. Romijn HJ, Hofman MA, Gramsbergen A (1991): At what age is the developing cerebral cortex of the rat comparable to that of the full-term newborn human baby? Early Hum Dev 26: 61-67.
27. United Nations Office of Drug Control and Crime (2007): 2007 World Drug Report (ISBN: 978-92-1-148222-5). New York, United Nations.
28. Winslow JT, Insel TR (1990): Serotonergic modulation of rat pup ultrasonic vocal development: studies with 3,4-methylenedioxymethamphetamine. J Pharmacol Exp Ther 254: 212-220.
29. Zetterström TSC, Pei Q, Madhav TR, Coppell AL, Lewis L, Grahame-Smith DG (1999): Manipulations of brain 5-HT levels affect gene expression for BDNF in rat brain. Neuropharmacology 38: 1063-1073.